Smith & Nephew
SNN
#1495
Rank
$14.51 B
Marketcap
$33.65
Share price
-0.74%
Change (1 day)
38.82%
Change (1 year)
Categories
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company.

P/E ratio for Smith & Nephew (SNN)

P/E ratio as of January 2026 (TTM): 30.2

According to Smith & Nephew 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 30.2139. At the end of 2013 the company had a P/E ratio of 18.1.

P/E ratio history for Smith & Nephew from 2001 to 2014

PE ratio at the end of each year

Year P/E ratio Change
201318.172.9%
201210.4-4.92%
201111.0

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
19.6-35.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
47.5 57.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
36.8 21.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
51.7 71.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Orthofix Medical
OFIX
-5.15-117.04%๐Ÿ‡บ๐Ÿ‡ธ USA
CONMED
CNMD
21.1-30.13%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.